Sequential bronchoplastic upper lobectomy as a surgical component of multimodal treatment for synchronous bilateral multiple primary non-small cell lung cancer

Relevance. Lung cancer (LC) is the leading cause of cancer-related death worldwide including Russia. Surgery remains the standard of care for early non-small cell lung cancer (NSCLC). However, as the disease progresses, the risk of metastasis increases, and the effectiveness of surgical intervention...

Full description

Bibliographic Details
Main Authors: O. I. Kit, I. N. Turkin, D. A. Kharagezov, Yu. N. Lazutin, I. A. Leiman, A. V. Chubaryan, E. A. Mirzoyan
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2022-06-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/2172
_version_ 1797875763665436672
author O. I. Kit
I. N. Turkin
D. A. Kharagezov
Yu. N. Lazutin
I. A. Leiman
A. V. Chubaryan
E. A. Mirzoyan
author_facet O. I. Kit
I. N. Turkin
D. A. Kharagezov
Yu. N. Lazutin
I. A. Leiman
A. V. Chubaryan
E. A. Mirzoyan
author_sort O. I. Kit
collection DOAJ
description Relevance. Lung cancer (LC) is the leading cause of cancer-related death worldwide including Russia. Surgery remains the standard of care for early non-small cell lung cancer (NSCLC). However, as the disease progresses, the risk of metastasis increases, and the effectiveness of surgical intervention decreases. The treatment strategy for patients presenting with a single NSCLC has long been developed. However, for patients with two or more tumors, especially in both lungs, the correct choice is determined by many additional factors. Currently, the view on the surgical treatment for synchronous multiple primary NSCLC has changed dramatically. However, patients with locally advanced synchronous NSCLC often receive conservative treatment, and for those who do undergo surgery, the prognostic factors are unclear. The disease prognosis in patients after surgical treatment for bilateral synchronous multiple primary NSCLC has now been proven to be favorable. Pneumonectomy is believed to have no any negative effect on survival; however, several authors reported on a 1.5-2-fold increase in postoperative mortality in a series of surgeries for synchronous NSCLC. Case description. We herein report a case in which extended bronchoplastic upper lobectomy was successfully applied in the treatment of a patient with bilateral synchronous NSCLC. Our experience demonstrates that the sequential application of modern therapeutic modalities results in satisfactory long-term outcomes in the treatment of locally advanced LC.Conclusion. Due to its uniqueness, this clinical case will be useful for developing treatment strategy for synchronous locally advanced NSCLC as well as for improving the quality of life of patients and increasing their survival.
first_indexed 2024-04-10T01:52:46Z
format Article
id doaj.art-fa2024d667c14249a169e666f39e975e
institution Directory Open Access Journal
issn 1814-4861
2312-3168
language Russian
last_indexed 2024-04-10T01:52:46Z
publishDate 2022-06-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj.art-fa2024d667c14249a169e666f39e975e2023-03-13T09:05:55ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682022-06-0121314315010.21294/1814-4861-2022-21-3-143-1501007Sequential bronchoplastic upper lobectomy as a surgical component of multimodal treatment for synchronous bilateral multiple primary non-small cell lung cancerO. I. Kit0I. N. Turkin1D. A. Kharagezov2Yu. N. Lazutin3I. A. Leiman4A. V. Chubaryan5E. A. Mirzoyan6ФГБУ «Национальный медицинский исследовательский центр онкологии» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии» Минздрава РоссииФГБУ «Национальный медицинский исследовательский центр онкологии» Минздрава РоссииRelevance. Lung cancer (LC) is the leading cause of cancer-related death worldwide including Russia. Surgery remains the standard of care for early non-small cell lung cancer (NSCLC). However, as the disease progresses, the risk of metastasis increases, and the effectiveness of surgical intervention decreases. The treatment strategy for patients presenting with a single NSCLC has long been developed. However, for patients with two or more tumors, especially in both lungs, the correct choice is determined by many additional factors. Currently, the view on the surgical treatment for synchronous multiple primary NSCLC has changed dramatically. However, patients with locally advanced synchronous NSCLC often receive conservative treatment, and for those who do undergo surgery, the prognostic factors are unclear. The disease prognosis in patients after surgical treatment for bilateral synchronous multiple primary NSCLC has now been proven to be favorable. Pneumonectomy is believed to have no any negative effect on survival; however, several authors reported on a 1.5-2-fold increase in postoperative mortality in a series of surgeries for synchronous NSCLC. Case description. We herein report a case in which extended bronchoplastic upper lobectomy was successfully applied in the treatment of a patient with bilateral synchronous NSCLC. Our experience demonstrates that the sequential application of modern therapeutic modalities results in satisfactory long-term outcomes in the treatment of locally advanced LC.Conclusion. Due to its uniqueness, this clinical case will be useful for developing treatment strategy for synchronous locally advanced NSCLC as well as for improving the quality of life of patients and increasing their survival.https://www.siboncoj.ru/jour/article/view/2172рак легкогомножественныйсинхронныйхирургическое лечениемультимодальная терапияпрогноз
spellingShingle O. I. Kit
I. N. Turkin
D. A. Kharagezov
Yu. N. Lazutin
I. A. Leiman
A. V. Chubaryan
E. A. Mirzoyan
Sequential bronchoplastic upper lobectomy as a surgical component of multimodal treatment for synchronous bilateral multiple primary non-small cell lung cancer
Сибирский онкологический журнал
рак легкого
множественный
синхронный
хирургическое лечение
мультимодальная терапия
прогноз
title Sequential bronchoplastic upper lobectomy as a surgical component of multimodal treatment for synchronous bilateral multiple primary non-small cell lung cancer
title_full Sequential bronchoplastic upper lobectomy as a surgical component of multimodal treatment for synchronous bilateral multiple primary non-small cell lung cancer
title_fullStr Sequential bronchoplastic upper lobectomy as a surgical component of multimodal treatment for synchronous bilateral multiple primary non-small cell lung cancer
title_full_unstemmed Sequential bronchoplastic upper lobectomy as a surgical component of multimodal treatment for synchronous bilateral multiple primary non-small cell lung cancer
title_short Sequential bronchoplastic upper lobectomy as a surgical component of multimodal treatment for synchronous bilateral multiple primary non-small cell lung cancer
title_sort sequential bronchoplastic upper lobectomy as a surgical component of multimodal treatment for synchronous bilateral multiple primary non small cell lung cancer
topic рак легкого
множественный
синхронный
хирургическое лечение
мультимодальная терапия
прогноз
url https://www.siboncoj.ru/jour/article/view/2172
work_keys_str_mv AT oikit sequentialbronchoplasticupperlobectomyasasurgicalcomponentofmultimodaltreatmentforsynchronousbilateralmultipleprimarynonsmallcelllungcancer
AT inturkin sequentialbronchoplasticupperlobectomyasasurgicalcomponentofmultimodaltreatmentforsynchronousbilateralmultipleprimarynonsmallcelllungcancer
AT dakharagezov sequentialbronchoplasticupperlobectomyasasurgicalcomponentofmultimodaltreatmentforsynchronousbilateralmultipleprimarynonsmallcelllungcancer
AT yunlazutin sequentialbronchoplasticupperlobectomyasasurgicalcomponentofmultimodaltreatmentforsynchronousbilateralmultipleprimarynonsmallcelllungcancer
AT ialeiman sequentialbronchoplasticupperlobectomyasasurgicalcomponentofmultimodaltreatmentforsynchronousbilateralmultipleprimarynonsmallcelllungcancer
AT avchubaryan sequentialbronchoplasticupperlobectomyasasurgicalcomponentofmultimodaltreatmentforsynchronousbilateralmultipleprimarynonsmallcelllungcancer
AT eamirzoyan sequentialbronchoplasticupperlobectomyasasurgicalcomponentofmultimodaltreatmentforsynchronousbilateralmultipleprimarynonsmallcelllungcancer